Changes

1.</ref> Moses (along with [[Robert C. Bailey]]) was responsible for one of the three major African circumcision trials (funded by NIAID and the Canadian Institutes of Health Research)<ref>{{cite journalREFjournal | authorlast=Krieger JN, Bailey RC, Opeya J, ''et al.'' | first= | coauthors= | pubyear=2005, November

| yearurl=2005 | monthaccessdate=November

|url=}}</ref> which are being used by the [[World Health Organization]] (under the guide of [[UNAIDS]]) to endorse circumcision as an HIV prevention method.<ref>{{REFweb {{cite web| last=World Health Organization | first= | year=2007-03-27 | title=WHO and UNAIDS announce recommendations from expert consultation on male circumcision for HIV prevention | url = http://www.who.int/hiv/mediacentre/news68/en/index.html | title = WHO and UNAIDS announce recommendations from expert consultation on male circumcision for HIV prevention | accessdate = 2011-02-23 | date = 2007-03-27 | publisher = World Health Organization

According to Stephen's bio, his interest is in biological and behavioural risk factors for STI/HIV transmission.<ref name='moses-bio'>{{cite webREFweb | last=Dr. Moses | first=Stephen | year= | title= | url = http://umanitoba.ca/faculties/medicine/units/medical_microbiology/faculty/StephenMoses.html | title = Dr. Stephen Moses | accessdate = 2011-02-23 | last = Moses | first = Stephen

}}</ref> Moses has been an advocate of circumcision since at least 1994.<ref>Moses S., Plummer FA, Bradley, JE, Ndinya-Achola, JO, Nagelkerke NJ, and Ronald AR. The association between lack of male circumcision and risk for HIV infection: a review of the epidemiological data. Sex Transm Dis 1994;21:201-10.</ref>

Of the three RCTs being used by the [[WHO]] to endorse circumcision as HIV prevention, Stephen Moses and [[Robert C. Bailey]] headed the RCT that was carried out in Kenya.<ref>Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007;369:643-56. [http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(07)60312-2/abstract Abstract]</ref> All three trials were funded by the American [[National Institutes of Health]].<ref name='DOC 2008'>{{cite webREFwebQuote | url quote= http://www.doctorsopposingcircumcision.org.funding from the United States National Institutes of Health to conduct randomized controlled trials (RCTs) in Africa. | last= | title first= The Use of Male Circumcision to Prevent HIV Infection | accessdate publisher= 2011-03-05Doctors Opposing Circumcision | date year= 2008 | publisher urltitle= Doctors Opposing The Use of Male Circumcisionto Prevent HIV Infection | archiveurl url= http://www.doctorsopposingcircumcision.org/info/HIVStatement.html | archivedate accessdate= 2011-03-05 | quote = ...funding from the United States National Institutes of Health to conduct randomized controlled trials (RCTs) in Africa.}}</ref>

*Prevalence and risk factors for human papillomavirus infection by penile site in uncircumcised Kenyan men.<ref>{{cite journalREFjournal | authorlast=Smith JS, Backes DM, Hudgens MG, ''et al.'' | first= | coauthors= | pubyear=2010, January

| yearurl=2010 | monthaccessdate=January

}}</ref> <p></pbr><small>Smith JS, Hudgens MG, '''[[Robert C. Bailey|Bailey RC]]''', Agot K, Ndinya-Achola JO, Moses S, et al. Int J Cancer 2010; 126: 572-7.</small>*Top Achievements in Health Research: Male circumcision: a new approach to reducing HIV transmission.<ref>{{cite journalREFjournal | authorlast=Moses S | first= | coauthors= | pubyear=2009, October

| yearurl=2009 | monthaccessdate=October

}}}</ref> <p></pbr><small>Moses S. CIHR/CMAJ 2009; 181: E134-5.</small><p></p> *Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of adult male circumcision clinical trials.<ref>{{cite journalREFjournal | authorlast=Mehta SD, Gray RH, Auvert B, ''et al.'' | first= | coauthors= | pubyear=2007, July

| yearurl=2009 | monthaccessdate=July

}}</ref> <p></pbr><small>Mehta SD, '''[[Ronald Gray|Gray RH]]''', '''[[Bertran Auvert|Auvert B]]''', Moses S , Kigozi G, Taljaard D, Puren A, Agot K, Serwadda D, Parker CB, '''[[Maria Wawer|Wawer MJ]]''', '''[[Robert C. Bailey|Bailey RC]]'''. AIDS 2009; 23: 1557-64.</small><p></p> *Male circumcision for HIV prevention in young men in Kisumu , Kenya: a randomised controlled trial.<ref>{{cite journalREFjournal | authorlast=Bailey RC, Moses S, Parker CB, ''et al.'' | first= | coauthors= | pubyear=2007, February

| yearurl=2007 | monthaccessdate=February

}}</ref> <p></pbr><small>'''[[Robert C. Bailey|Bailey RC]]''', Moses S , Parker CB, Agot K, Maclean I, Krieger JN, et al. Lancet 2007; 369: 643-56.</small><p></p>*Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa.<ref>{{cite journalREFjournal | authorlast=Nagelkerke NJ, Moses S, de Vlas SJ, Bailey RC | first= | coauthors= | pubyear=2007

| yearurl= | accessdate=2007

}}</ref> <p></pbr><small>Nagelkerke NJD, Moses S, de Vlas S, '''[[Robert C. Bailey|Bailey RC]]'''. BMC Infect Dis 2007; 7: 16.</small><p></p>*Adult male circumcision outcomes: experience in a developing country setting.<ref>{{cite journalREFjournal | authorlast=Krieger JN, Bailey RC, Opeya JC, ''et al.'' | first= | coauthors= | pubyear=2007

| yearurl= | accessdate=2007

}}</ref> <p></pbr><small>Krieger J, '''[[Robert C. Bailey|Bailey RC]]''', Agot K, Parker C, Ndinya-Achola JO, Moses S, et al. Urol Int 2007; 78: 235-40.</small><p></p>